# BETA — Beta Drugs Limited

> Beta Drugs Limited (BETA) on the NSE: 2,046 sessions of split-adjusted history from 2017.

Canonical: https://patternsradar.com/s/BETA

## Latest session

- Close: 2,327.7 INR (1.42% on the day), 2026-08-21
- Delivery: 47.45% of volume taken to demat (20-day average 47.63%)
- Volume: 18.3K shares, turnover ₹4.3Cr
- Relative volume: 0.4× of its own 20-day average

## Technicals

- RSI(14): 49.07
- ATR(14): 155.72
- SMA 50: 2,246.35, SMA 200: 1,629.72
- 52-week range: 990.1 – 2,807.9 (-17.1% from the high)

## Performance

- 1 week -8.74%, 1 month 2.22%, 3 months 69.08%
- 6 months 106.01%, 1 year 19.97%

## Fundamentals

- Market cap: 2,580.5 crore
- P/E (TTM): 44.52 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 52.29 INR, split-adjusted to match the price series
- Revenue growth: — YoY, 33.61% QoQ
- Profit growth: — YoY, 82.18% QoQ

## Quarterly results

Last 5 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2025-03-31 | 182.1 | 158.2 | 24.2 | 18 | 17.81 | 9.88% |
| 2025-09-30 | 203.6 | 177.5 | 32.1 | 23.9 | 47.38 | 11.75% |
| 2025-12-31 | 87.3 | 79.1 | 10.5 | 8.5 | 8.4 | 9.76% |
| 2026-03-31 | 94 | 85 | 11.8 | 9 | 8.93 | 9.63% |
| 2026-06-30 | 125.5 | 105.1 | 22 | 16.5 | 14.78 | 13.13% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 59.1%
- Public: 40.9%

Institutional and pledge percentages come from a filing stage whose backfill has reached about 1% of instruments, so they are absent here rather than zero.

## Recent filings

- 2026-07-20: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_175943_20072026133938_iXBRL_WEB.html
- 2026-07-17: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1694796_17072026105957_WEB.xml
- 2026-06-11: shareholding for 2026-05-25 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1680972_11062026055201_WEB.xml
- 2026-05-14: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_157610_14052026183917_iXBRL_WEB.html
- 2026-04-06: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1646119_06042026124204_WEB.xml
- 2026-02-14: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_143383_14022026140529_iXBRL_WEB.html
- 2026-01-13: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1599517_13012026011403_WEB.xml
- 2025-11-06: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_NONINDAS_124893_06112025184604_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 28 events are indexed for this instrument.

## About the instrument

- Listed: 2017-10-12 — latest session 2026-08-21 (2,046 sessions)
- ISIN: INE351Y01019
- Series: EQ
- Liquidity rank: #989 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/BETA.